hepatomegaly
Showing 1 - 9 of 9
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of
Recruiting
- BCR-JAK2 Fusion Protein Expression
- +11 more
-
Palo Alto, California
- +3 more
Oct 5, 2022
Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea Trial in United States (Isatuximab, Laboratory Biomarker
Active, not recruiting
- Amorphous, Eosinophilic, and Acellular Deposit
- +12 more
- Isatuximab
- Laboratory Biomarker Analysis
-
Anchorage, Alaska
- +344 more
Aug 22, 2022
Biomarker for Farber Disease (BioFarber)
Active, not recruiting
- Farber's Lipogranulomatosis
- +3 more
-
Cairo, Egypt
- +2 more
May 17, 2021
Biomarker for Sly Disease (MPS VII) (BioSly)
Active, not recruiting
- Developmental Delay
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis
Terminated
- Hepatomegaly
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 23, 2019
Hepatomegaly in Children and Type 1 Diabetes Mellitus
Unknown status
- Hepatomegaly
-
Assiut, EgyptAssiut children hospital
Sep 10, 2018
Polycystic Kidney, Autosomal Dominant, Polycystic Liver Disease, Hepatomegaly Trial in Rochester (Octreotide, Placebo)
Completed
- Polycystic Kidney, Autosomal Dominant
- +5 more
- Octreotide
- Placebo
-
Rochester, MinnesotaMayo Clinic
Oct 22, 2012
